Correlation Between GlaxoSmithKline PLC and VeriSign

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and VeriSign at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and VeriSign into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and VeriSign, you can compare the effects of market volatilities on GlaxoSmithKline PLC and VeriSign and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of VeriSign. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and VeriSign.

Diversification Opportunities for GlaxoSmithKline PLC and VeriSign

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GlaxoSmithKline and VeriSign is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and VeriSign in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VeriSign and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with VeriSign. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VeriSign has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and VeriSign go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and VeriSign

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.93 times more return on investment than VeriSign. However, GlaxoSmithKline PLC ADR is 1.08 times less risky than VeriSign. It trades about 0.01 of its potential returns per unit of risk. VeriSign is currently generating about -0.01 per unit of risk. If you would invest  3,385  in GlaxoSmithKline PLC ADR on August 29, 2024 and sell it today you would earn a total of  17.00  from holding GlaxoSmithKline PLC ADR or generate 0.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.21%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  VeriSign

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
VeriSign 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in VeriSign are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, VeriSign is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

GlaxoSmithKline PLC and VeriSign Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and VeriSign

The main advantage of trading using opposite GlaxoSmithKline PLC and VeriSign positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, VeriSign can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VeriSign will offset losses from the drop in VeriSign's long position.
The idea behind GlaxoSmithKline PLC ADR and VeriSign pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites